ArticlebioRxiv : the preprint server for biology2026
PRISME: A MATLAB Toolbox For Large Data-Driven Multimodal Power Benchmarking.
Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Low statistical power in neuroimaging often undermines research in the field, leading to missed effects, wasted resources, and reduced reproducibility. Performing power analyses during the study design phase is extremely important, but often prohibitively difficult due to a lack of analytical solutions and high computational costs. We present PRISME (Power Resampling Infrastructure for Statistical Method Evaluation), a MATLAB toolbox for neuroimaging power benchmarking. PRISME provides a computational framework for empirical power analysis independent of inference methods, enabling large scale power benchmarking and method comparison. The toolbox supports diverse neuroimaging data types, including both voxel-based activation and functional connectivity analyses, with a non-parametric, flexible algorithm and unified data representations. Furthermore, unlike previous empirical power approaches, PRISME supports multiple test types, such as association and difference tests with behavioral and clinical measures. Finally, PRISME's 25× speedup from algorithmic optimizations enables larger-scale power benchmarking, including the first power analysis for the ABCD dataset. Overall, PRISME is the first method- and data-type-agnostic power benchmarking tool for neuroimaging, providing a single solution for power analysis across diverse study designs.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.